» Articles » PMID: 26876937

Nuclear M(6)A Reader YTHDC1 Regulates MRNA Splicing

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2016 Feb 16
PMID 26876937
Citations 1068
Authors
Affiliations
Soon will be listed here.
Abstract

The regulatory role of N(6)-methyladenosine (m(6)A) and its nuclear binding protein YTHDC1 in pre-mRNA splicing remains an enigma. Here we show that YTHDC1 promotes exon inclusion in targeted mRNAs through recruiting pre-mRNA splicing factor SRSF3 (SRp20) while blocking SRSF10 (SRp38) mRNA binding. Transcriptome assay with PAR-CLIP-seq analysis revealed that YTHDC1-regulated exon-inclusion patterns were similar to those of SRSF3 but opposite of SRSF10. In vitro pull-down assay illustrated a competitive binding of SRSF3 and SRSF10 to YTHDC1. Moreover, YTHDC1 facilitates SRSF3 but represses SRSF10 in their nuclear speckle localization, RNA-binding affinity, and associated splicing events, dysregulation of which, as the result of YTHDC1 depletion, can be restored by reconstitution with wild-type, but not m(6)A-binding-defective, YTHDC1. Our findings provide the direct evidence that m(6)A reader YTHDC1 regulates mRNA splicing through recruiting and modulating pre-mRNA splicing factors for their access to the binding regions of targeted mRNAs.

Citing Articles

YTHDC1 negatively regulates UBE3A to influence RAD51 ubiquitination and inhibit apoptosis in colorectal cancer cells.

Gao M, Wu Y, Zhang L, Zhou Y, Liu H, Zhang W Sci Rep. 2025; 15(1):8857.

PMID: 40087295 DOI: 10.1038/s41598-025-92925-6.


Natural product mediated mesenchymal-epithelial remodeling by covalently binding ENO1 to degrade m6A modified -catenin mRNA.

Chen T, Liu G, Chen S, Zhang F, Ma S, Bai Y Acta Pharm Sin B. 2025; 15(1):467-483.

PMID: 40041899 PMC: 11873566. DOI: 10.1016/j.apsb.2024.07.013.


The potential impact of RNA splicing abnormalities on immune regulation in endometrial cancer.

Cao M, Yan J, Ding Y, Zhang Y, Sun Y, Jiang G Cell Death Dis. 2025; 16(1):148.

PMID: 40032844 PMC: 11876696. DOI: 10.1038/s41419-025-07458-7.


m6A RNA methylation: a pivotal regulator of tumor immunity and a promising target for cancer immunotherapy.

Chen X, Yuan Y, Zhou F, Li L, Pu J, Jiang X J Transl Med. 2025; 23(1):245.

PMID: 40022120 PMC: 11871626. DOI: 10.1186/s12967-025-06221-y.


Novel Insight of N6-Methyladenosine in Cardiovascular System.

Zhang H, Lu W, Tang H, Chen A, Gao X, Zhu C Medicina (Kaunas). 2025; 61(2).

PMID: 40005339 PMC: 11857502. DOI: 10.3390/medicina61020222.